Skip to content

Welldoc v2.1

by Welldoc 5 variants

Welldoc v2.1, a home pharmaceutical management support software (FDA Class II; FDA product code NDC, Calculator, Drug Dose) made by Welldoc, was cleared under FDA 510(k) K203434 on 8 Sep 2021 and listed in FDA GUDID on 15 Dec 2023 (UDI-DI B553202051OTC0); the registry lists it as not in commercial distribution (GUDID) as of 23 Oct 2026.

Active United States. Also listed in GUDID (US), not in commercial distribution.

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K203434

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB553202051OTC0 UDI-DI Date15 Dec 2023ListedStatusListed GUDID: not in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK203434 Date8 Sep 2021DecidedStatusActive

Official records

From the FDA record

Device description
Welldoc Diabetes is indicated for use by healthcare providers (HCPs) and their patients – aged 18 years and older - who have type 1 or type 2 diabetes. Welldoc Diabetes is intended to provide secure capture, storage, and transmission of blood glucose data as well as information to aid in diabetes self-management. Welldoc Diabetes analyzes and reports blood glucose test results and supports medication adherence. In addition, Welldoc Diabetes provides coaching messages (motivational, behavioral, and educational) based on real-time blood glucose values and trends. It includes software intended for use on mobile phones or personal computers in the home or in professional healthcare settings. The software also allows for entry of other diabetes-related healthcare information and provides educational information. Welldoc Diabetes is not intended to replace the care provided by a licensed healthcare professional, including prescriptions, diagnosis, or treatment. Welldoc also includes other functions that are designed to maintain, encourage a healthy lifestyle or help users manage their disease or condition without providing specific treatment or treatment suggestions.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K203434 decided 8 Sep 2021 Active
  • FDA GUDID UDI-DI B553202051OTC0 listed 15 Dec 2023 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K203434
  2. Listed FDA GUDID B553202051OTC0

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Welldoc
Generic name
Home pharmaceutical management support software
Model / reference
v2.1
Primary DI / UDI-DI
B553202051OTC0
510(k) Number
FDA product code
NDC
GMDN term
Home pharmaceutical management support software
Device class
Class II
Regulation number
868.1890
GUDID distribution status
Not in Commercial Distribution

Similar devices

Other devices filed under FDA product code NDC (Calculator, Drug Dose).

Other devices from Welldoc

See all devices from Welldoc →

Properties

  • Over-the-counter
  • Lot / batch number
Other properties (13, all answered No)